The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer. (ISRCTN 12808747) TRAPEZE.
 
Nicholas David James
Honoraria - Astellas Pharma; Bayer; Janssen; Oncogenex; Pierre Fabre; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Merck; Sanofi
Speakers' Bureau - Astellas Pharma; Ferring; Pierre Fabre; Sanofi
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Pfizer (Inst); Sanofi (Inst)
 
Lazaros Andronis
No Relationships to Disclose
 
Ilias Goranitis
No Relationships to Disclose
 
Sarah Pirrie
No Relationships to Disclose
 
Ann Pope
No Relationships to Disclose
 
Darren Barton
No Relationships to Disclose
 
Adam Daunton
No Relationships to Disclose
 
Duncan McLaren
No Relationships to Disclose
 
Joe M. O'Sullivan
No Relationships to Disclose
 
Chris Parker
Consulting or Advisory Role - Bayer Schering Pharma; BN ImmunoTherapeutics; Janssen
Research Funding - Bayer Schering Pharma (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Janssen
 
John Staffurth
No Relationships to Disclose
 
Andrew Stanley
No Relationships to Disclose
 
James Wylie
No Relationships to Disclose
 
Sharon Beesley
No Relationships to Disclose
 
Alison J. Birtle
No Relationships to Disclose
 
Janet Elizabeth Brown
Consulting or Advisory Role - Amgen; Novartis
Speakers' Bureau - GlaxoSmithKline
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for biomarker for bone metastasis (Inst)
 
Prabir R Chakraborti
No Relationships to Disclose
 
John Martin Russell
No Relationships to Disclose
 
Lucinda Billingham
No Relationships to Disclose